{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:07:55Z","timestamp":1789834075791,"version":"4.0.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00535-021-01762-7","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T17:03:30Z","timestamp":1614186210000},"page":"382-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-3083","authenticated-orcid":false,"given":"Tsuyoshi","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Takami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Sakaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"1762_CR1","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/hep.21665","volume":"45","author":"F Vizzutti","year":"2007","unstructured":"Vizzutti F, Arena U, Romanelli RG, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45:1290\u20137.","journal-title":"Hepatology"},{"key":"1762_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrgastro.2009.149","volume":"6","author":"J Bosch","year":"2009","unstructured":"Bosch J, Abraldes JG, Berzigotti A, et al. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6:573\u201382.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1762_CR3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis R, Baveno VI. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63:743\u201352.","journal-title":"J Hepatol."},{"key":"1762_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00508-017-1262-3","volume":"129","author":"T Reiberger","year":"2017","unstructured":"Reiberger T, P\u00fcsp\u00f6k A, Schoder M, et al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wien Klin Wochenschr. 2017;129:135\u201358.","journal-title":"Wien Klin Wochenschr"},{"key":"1762_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11901-019-00469-x","volume":"18","author":"M Mandorfer","year":"2019","unstructured":"Mandorfer M, Hern\u00e1ndez-Gea V, Reiberger T, et al. Hepatic venous pressure gradient response in non-selective beta-blocker treatment\u2014Is it worth measuring? Curr Hepatol Rep. 2019;18:174\u201386.","journal-title":"Curr Hepatol Rep"},{"key":"1762_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","volume":"133","author":"C Ripoll","year":"2007","unstructured":"Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481\u20138.","journal-title":"Gastroenterology"},{"key":"1762_CR7","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jhep.2009.01.014","volume":"50","author":"C Ripoll","year":"2009","unstructured":"Ripoll C, Groszmann RJ, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol. 2009;50:923\u20138.","journal-title":"J Hepatol"},{"key":"1762_CR8","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1572-0241.2007.01481.x","volume":"102","author":"G Garcia-Tsao","year":"2007","unstructured":"Garcia-Tsao G, Sanyal AJ, Grace ND, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007;102:2086\u2013102.","journal-title":"Am J Gastroenterol"},{"key":"1762_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","volume":"137","author":"C Villanueva","year":"2009","unstructured":"Villanueva C, Aracil C, Colomo A, et al. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding. Gastroenterology. 2009;137:119\u201328.","journal-title":"Gastroenterology"},{"key":"1762_CR10","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJMra0901512","volume":"362","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med. 2010;362:823\u201332.","journal-title":"N Engl J Med"},{"key":"1762_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2214\/ajr.132.5.777","volume":"132","author":"DG Spigos","year":"1979","unstructured":"Spigos DG, Jonasson O, Mozes M, et al. Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol. 1979;132:777\u201382.","journal-title":"AJR Am J Roentgenol"},{"key":"1762_CR12","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1007\/BF00686666","volume":"33","author":"M Mukaiya","year":"1994","unstructured":"Mukaiya M, Hirata K, Yamashiro K, et al. Changes in portal hemodynamics and hepatic function after partial splenic embolization (PSE) and percutaneous transhepatic obliteration (PTO). Cancer Chemother Pharmacol. 1994;33:S37-41.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1762_CR13","first-page":"1847","volume":"54","author":"F Chikamori","year":"2007","unstructured":"Chikamori F, Kuniyoshi N, Kawashima T, et al. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism. Hepatogastroenterology. 2007;54:1847\u20139.","journal-title":"Hepatogastroenterology"},{"key":"1762_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/hep.1840180214","volume":"18","author":"B Sangro","year":"1993","unstructured":"Sangro B, Bilbao I, Herrero I, et al. Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology. 1993;18:309\u201314.","journal-title":"Hepatology"},{"key":"1762_CR15","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/hep.1840220611","volume":"22","author":"H Noguchi","year":"1995","unstructured":"Noguchi H, Hirai K, Aoki Y, et al. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology. 1995;22:1682\u20138.","journal-title":"Hepatology"},{"key":"1762_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00042737-200502000-00008","volume":"17","author":"G N'Kontchou","year":"2005","unstructured":"N\u2019Kontchou G, Seror O, Bourcier V, et al. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005;17:179\u201384.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1762_CR17","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s10620-006-3137-8","volume":"51","author":"K Ohmoto","year":"2006","unstructured":"Ohmoto K, Yoshioka N, Tomiyama Y, et al. Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci. 2006;51:352\u20138.","journal-title":"Dig Dis Sci"},{"key":"1762_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177401","author":"M Buechter","year":"2017","unstructured":"Buechter M, Kahraman A, Manka P, et al. Partial spleen embolization reduces the risk of portal hypertension-induced upper gastrointestinal bleeding in patients not eligible for TIPS implantation. PLoS ONE. 2017. https:\/\/doi.org\/10.1371\/journal.pone.0177401.","journal-title":"PLoS ONE"},{"key":"1762_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223153","author":"T Ishikawa","year":"2019","unstructured":"Ishikawa T, Sasaki R, Nishimura T, et al. A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification. PLoS ONE. 2019. https:\/\/doi.org\/10.1371\/journal.pone.0223153.","journal-title":"PLoS ONE"},{"key":"1762_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s002709900119","volume":"20","author":"MJ Han","year":"1997","unstructured":"Han MJ, Zhao HG, Ren K, et al. Partial splenic embolization for hypersplenism concomitant with or after arterial embolization of hepatocellular carcinoma in 30 patients. Cardiovasc Intervent Radiol. 1997;20:125\u20137.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1762_CR21","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1111\/j.1440-1746.2007.05090.x","volume":"22","author":"H Hayashi","year":"2007","unstructured":"Hayashi H, Beppu T, Masuda T, et al. Predictive factors for platelet increase after partial splenic embolization in liver cirrhosis patients. J Gastroenterol Hepatol. 2007;22:1638\u201342.","journal-title":"J Gastroenterol Hepatol"},{"key":"1762_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jvir.2012.03.008","volume":"23","author":"A Osaki","year":"2012","unstructured":"Osaki A, Suda T, Waguri N, et al. Formula to predict platelet count after partial splenic arterial embolization in patients with hypersplenism. J Vasc Interv Radiol. 2012;23:900\u20137.","journal-title":"J Vasc Interv Radiol"},{"key":"1762_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0301-5629(02)00489-1","volume":"28","author":"WC Yeh","year":"2002","unstructured":"Yeh WC, Li PC, Jeng YM, et al. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol. 2002;28:467\u201374.","journal-title":"Ultrasound Med Biol"},{"key":"1762_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2169\/internalmedicine.48.1649","volume":"48","author":"H Shimizu","year":"2009","unstructured":"Shimizu H, Takatsuka K, Yoshida A, et al. Partial splenic embolization reverses insulin resistance in patients with liver cirrhosis. Intern Med. 2009;48:747\u201351.","journal-title":"Intern Med"},{"key":"1762_CR25","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/bjs.6081","volume":"95","author":"H Hayashi","year":"2008","unstructured":"Hayashi H, Beppu T, Okabe K, et al. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. 2008;95:744\u201350.","journal-title":"Br J Surg"},{"key":"1762_CR26","doi-asserted-by":"publisher","first-page":"W169","DOI":"10.2214\/AJR.16.17307","volume":"209","author":"T Ishikawa","year":"2017","unstructured":"Ishikawa T, Aibe Y, Matsuda T, et al. Plasma glucose level is predictive of serum ammonia level after retrograde occlusion of portosystemic shunts. AJR Am J Roentgenol. 2017;209:W169\u201376.","journal-title":"AJR Am J Roentgenol"},{"key":"1762_CR27","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254\u201361.","journal-title":"N Engl J Med."},{"key":"1762_CR28","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1053\/jhep.2000.19322","volume":"32","author":"C Merkel","year":"2000","unstructured":"Merkel C, Bolognesi M, Sacerdoti D, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000;32:930\u20134.","journal-title":"Hepatology"},{"key":"1762_CR29","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00535-010-0360-z","volume":"46","author":"A Berzigotti","year":"2011","unstructured":"Berzigotti A, Rossi V, Tiani C, et al. Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension. J Gastroenterol. 2011;46:687\u201395.","journal-title":"J Gastroenterol"},{"key":"1762_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/hep.20871","volume":"42","author":"C Ripoll","year":"2005","unstructured":"Ripoll C, Ba\u00f1ares R, Rinc\u00f3n D, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology. 2005;42:793\u2013801.","journal-title":"Hepatology"},{"key":"1762_CR31","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/hep.22358","volume":"48","author":"GH Lo","year":"2008","unstructured":"Lo GH, Chen WC, Lin CK, et al. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology. 2008;48:580\u20137.","journal-title":"Hepatology"},{"key":"1762_CR32","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1572-0241.2007.01191.x","volume":"102","author":"A Albillos","year":"2007","unstructured":"Albillos A, Ba\u00f1ares R, Gonz\u00e1lez M, et al. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis. Am J Gastroenterol. 2007;102:1116\u201326.","journal-title":"Am J Gastroenterol"},{"key":"1762_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.12.001","author":"SG Rodrigues","year":"2019","unstructured":"Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in cirrhosis: evidence-based indications and limitations. JHEP Rep. 2019. https:\/\/doi.org\/10.1016\/j.jhepr.2019.12.001.","journal-title":"JHEP Rep"},{"key":"1762_CR34","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/S0016-5085(84)80106-7","volume":"86","author":"K Okuda","year":"1984","unstructured":"Okuda K, Kono K, Ohnishi K, et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology. 1984;86:600\u201310.","journal-title":"Gastroenterology"},{"key":"1762_CR35","first-page":"573","volume":"41","author":"RJ Gusberg","year":"1994","unstructured":"Gusberg RJ, Peterec SM, Sumpio BE, et al. Splenomegaly and variceal bleeding\u2013hemodynamic basis and treatment implications. Hepatogastroenterology. 1994;41:573\u20137.","journal-title":"Hepatogastroenterology"},{"key":"1762_CR36","first-page":"1726","volume":"49","author":"J Kaneko","year":"2002","unstructured":"Kaneko J, Sugawara Y, Matsui Y, et al. Normal splenic volume in adults by computed tomography. Hepatogastroenterology. 2002;49:1726\u20137.","journal-title":"Hepatogastroenterology"},{"key":"1762_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00276-008-0364-z","volume":"30","author":"J Kaneko","year":"2008","unstructured":"Kaneko J, Sugawara Y, Matsui Y, et al. Spleen size of live donors for liver transplantation. Surg Radiol Anat. 2008;30:515\u20138.","journal-title":"Surg Radiol Anat"},{"key":"1762_CR38","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1016\/j.ejrad.2009.08.013","volume":"75","author":"A Harris","year":"2010","unstructured":"Harris A, Kamishima T, Hao HY. Splenic volume measurements on computed tomography utilizing automatically contouring software and its relationship with age, gender, and anthropometric parameters. Eur J Radiol. 2010;75:e97-101.","journal-title":"Eur J Radiol"},{"key":"1762_CR39","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017900","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Guo L, Huang Q, et al. Observation of immediate and mid-term effects of partial spleen embolization in reducing hepatic venous pressure gradient. Medicine (Baltimore). 2019. https:\/\/doi.org\/10.1097\/MD.0000000000017900.","journal-title":"Medicine (Baltimore)"},{"key":"1762_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322367","author":"A Yamamoto","year":"2020","unstructured":"Yamamoto A, Kawada N, Jogo A, et al. Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein. Gut. 2020. https:\/\/doi.org\/10.1136\/gutjnl-2020-322367.","journal-title":"Gut"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-021-01762-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-021-01762-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-021-01762-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T07:04:32Z","timestamp":1616915072000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-021-01762-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s00535-021-01762-7","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"assertion":[{"value":"16 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest concerning this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}